Page last updated: 2024-09-05

erlotinib hydrochloride and Myofibromatosis

erlotinib hydrochloride has been researched along with Myofibromatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Macigova, P; Mudry, P; Neradil, J; Noskova, H; Polaskova, K; Slaby, O; Sramek, M; Sterba, J; Veselska, R	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Myofibromatosis

Article	Year
Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a International journal of molecular sciences, 2018, Sep-01, Volume: 19, Issue:9 Topics: Butadienes; Cell Line, Tumor; Cell Proliferation; Child; Erlotinib Hydrochloride; Female; Humans; Infant; Male; Mutation; Myofibromatosis; Nitriles; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyridazines; Receptor, Platelet-Derived Growth Factor beta; Sunitinib	2018

Article

Year

Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a

International journal of molecular sciences, 2018, Sep-01, Volume: 19, Issue:9

Topics: Butadienes; Cell Line, Tumor; Cell Proliferation; Child; Erlotinib Hydrochloride; Female; Humans; Infant; Male; Mutation; Myofibromatosis; Nitriles; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyridazines; Receptor, Platelet-Derived Growth Factor beta; Sunitinib

2018